Zentalis Pharmaceuticals

Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing small molecule therapeutics targeting fundamental biological pathways of cancers. They generate revenue primarily through partnerships, licensing agreements, and potential future product sales. Founded in 2014, Zentalis has made significant strides in oncology, with a robust pipeline of drug candidates aimed at treating various cancers. Their innovative approach and strategic collaborations position them as a key player in the biopharmaceutical industry.

Recent Posts by Zentalis Pharmaceuticals

1-4 of 4